Vandana Abramson

Vandana Abramson

UNVERIFIED PROFILE

Are you Vandana Abramson?   Register this Author

Register author
Vandana Abramson

Vandana Abramson

Publications by authors named "Vandana Abramson"

Are you Vandana Abramson?   Register this Author

60Publications

1589Reads

21Profile Views

Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer.

N Engl J Med 2019 02;380(8):741-751

From the Massachusetts General Hospital Cancer Center (A.B., S.J.I.) and Dana-Farber Cancer Institute (S.M.T.), Harvard Medical School, Boston; Vanderbilt-Ingram Cancer Center, Nashville (I.A.M., V.G.A.); Weill Cornell Medical College (L.T.V.) and New York-Presbyterian-Columbia University Irving Medical Center (K.K.), New York; University of Colorado Cancer Center, Aurora (J.R.D.); Texas Oncology, Baylor University Medical Center, US Oncology, Dallas (J.O.); Orlando Health University of Florida Health Cancer Center, Orlando (R.L.M., N.C.S.); Yale University School of Medicine, New Haven, CT (A.D.S.); University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco (H.S.R.); Immunomedics, Morris Plains, NJ (D.M.G., R.I., S.W., R.M.S., W.A.W.); and AIS Consulting, Ann Arbor, MI (A.M.S.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1814213
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1814213DOI Listing
February 2019

Surgical Findings and Outcomes in Premenopausal Breast Cancer Patients Undergoing Oophorectomy: A Multicenter Review From the Society of Gynecologic Surgeons Fellows Pelvic Research Network.

J Minim Invasive Gynecol 2018 01 15;25(1):111-115. Epub 2017 Aug 15.

Division of Minimally Invasive Gynecology, Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, Tennessee.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmig.2017.08.643DOI Listing
January 2018

Ketoacidosis With Canagliflozin Prescribed for Phosphoinositide 3-Kinase Inhibitor-Induced Hyperglycemia: A Case Report.

J Investig Med High Impact Case Rep 2017 Jul-Sep;5(3):2324709617725351. Epub 2017 Aug 23.

Vanderbilt University Medical Center, Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2324709617725351DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571767PMC
August 2017

Efficacy and Safety of Anti-Trop-2 Antibody Drug Conjugate Sacituzumab Govitecan (IMMU-132) in Heavily Pretreated Patients With Metastatic Triple-Negative Breast Cancer.

J Clin Oncol 2017 Jul 14;35(19):2141-2148. Epub 2017 Mar 14.

Aditya Bardia, Steven J. Isakoff, and Dejan Juric, Massachusetts General Hospital Cancer Center; Aditya Bardia, Steven J. Isakoff, Dejan Juric, and Sara M. Tolaney, Harvard Medical School; Sara M. Tolaney, Dana-Farber Cancer Institute, Boston, MA; Ingrid A. Mayer, Vandana Abramson, and Jordan Berlin, Vanderbilt-Ingram Cancer Center, Nashville, TN; Jennifer R. Diamond and Wells A. Messersmith, University of Colorado Cancer Center, Aurora, CO; Rebecca L. Moroose and Nikita C. Shah, University of Florida Health Cancer Center, Orlando, FL; Alexander N. Starodub, Indiana University Health Center for Cancer Care, Goshen, IN; Joyce O'Shaughnessy, Texas Oncology-Baylor Charles A. Sammons Cancer Center; Joyce O'Shaughnessy, US Oncology, Dallas, TX; Kevin Kalinsky, Columbia University Herbert Irving Comprehensive Cancer Center; Allyson J. Ocean and Linda T. Vahdat, Weill Cornell Medicine, New York, NY; Michael Guarino, Helen F. Graham Cancer Center, Newark, DE; William A. Wegener, Pius Maliakal, Robert M. Sharkey, Serengulam V. Govindan, and David M. Goldenberg, Immunomedics, Morris Plains, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.8297DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559902PMC
July 2017

The Evolution of Triple-Negative Breast Cancer: From Biology to Novel Therapeutics.

Am Soc Clin Oncol Educ Book 2016 ;35:34-42

From the Department of Medicine, Vanderbilt University, Vanderbilt-Ingram Cancer Center, Nashville, TN; Department of Medicine, National Cancer Center Singapore, Singapore; Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_159135DOI Listing
January 2017

Towards real-time topical detection and characterization of FDG dose infiltration prior to PET imaging.

Eur J Nucl Med Mol Imaging 2016 Dec 25;43(13):2374-2380. Epub 2016 Aug 25.

Institute for Computational and Engineering Sciences, and Departments of Biomedical Engineering and Internal Medicine, The University of Texas at Austin, Austin, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-016-3477-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096989PMC
December 2016

Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: American Society of Clinical Oncology Endorsement of Cancer Care Ontario Guideline Recommendations.

J Clin Oncol 2016 07 21;34(19):2303-11. Epub 2016 Mar 21.

N. Lynn Henry, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Mark R. Somerfield, American Society of Clinical Oncology, Alexandria, VA; Vandana G. Abramson, Vanderbilt-Ingram Cancer Center, Nashville, TN; Kimberly H. Allison, Stanford University Medical Center, Stanford; Diana T. Chingos, University of Southern California/Young Survival Coalition, Los Angeles; Arti Hurria, City of Hope, Duarte, CA; Carey K. Anders, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; Thomas H. Openshaw, Eastern Maine Medical Center Cancer Care, Brewer, ME; and Ian E. Krop, Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.8609DOI Listing
July 2016

Analysis of Risk of Recurrence by Subtype in ≤ 1-cm Breast Tumors.

Clin Breast Cancer 2016 Jun 6;16(3):223-31. Epub 2015 Nov 6.

Vanderbilt-Ingram Cancer Center, Nashville, TN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2015.10.001DOI Listing
June 2016

Predicting the Response of Breast Cancer to Neoadjuvant Therapy Using a Mechanically Coupled Reaction-Diffusion Model.

Cancer Res 2015 Nov 2;75(22):4697-707. Epub 2015 Sep 2.

Institute of Imaging Science, Vanderbilt University, Nashville, Tennessee. Department of Radiology and Radiological Sciences, Vanderbilt University, Nashville, Tennessee. Department of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee. Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee. Department of Physics, Vanderbilt University, Nashville, Tennessee. Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/cgi/doi/10.1158/0008-5472.
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-14-2945DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4651826PMC
November 2015

Current HER2 Testing Recommendations and Clinical Relevance as a Predictor of Response to Targeted Therapy.

Clin Breast Cancer 2015 Jun 2;15(3):171-80. Epub 2014 Dec 2.

Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN; Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2014.11.009DOI Listing
June 2015

Multiparametric magnetic resonance imaging for predicting pathological response after the first cycle of neoadjuvant chemotherapy in breast cancer.

Invest Radiol 2015 Apr;50(4):195-204

From the *Institute of Imaging Science, †Department of Radiology and Radiological Sciences, ‡the Vanderbilt-Ingram Cancer Center, Departments of §Biostatistics, ∥Radiation Oncology, ¶Medical Oncology, #Surgical Oncology, **Pathology, ††Physics and Astronomy, ‡‡Cancer Biology, and §§Biomedical Engineering, Vanderbilt University, Nashville, TN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLI.0000000000000100DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471951PMC
April 2015

Detection of breast cancer microcalcification using (99m)Tc-MDP SPECT or Osteosense 750EX FMT imaging.

Nucl Med Biol 2015 Mar 6;42(3):269-73. Epub 2014 Dec 6.

Vanderbilt University Institute of Imaging Science, Vanderbilt University Medical Center, Vanderbilt University, Nashville, TN 37232, USA; Department of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Vanderbilt University, Nashville, TN 37232, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09698051140054
Publisher Site
http://dx.doi.org/10.1016/j.nucmedbio.2014.11.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4889014PMC
March 2015

Subtyping of triple-negative breast cancer: implications for therapy.

Cancer 2015 Jan 16;121(1):8-16. Epub 2014 Jul 16.

Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee; Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28914DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4270831PMC
January 2015

Kinome-wide functional screen identifies role of PLK1 in hormone-independent, ER-positive breast cancer.

Cancer Res 2015 Jan 5;75(2):405-14. Epub 2014 Dec 5.

Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee. Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee. Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, Tennessee.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-14-2475DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4297507PMC
January 2015

Molecular Heterogeneity of Triple Negative Breast Cancer.

Curr Breast Cancer Rep 2014 Sep;6(3):154-158

Department of Medicine; Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center; Vanderbilt University School of Medicine, Nashville, TN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12609-014-0152-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4235783PMC
September 2014

Sympathetic nervous system alterations with HER2+ antagonism: an early marker of cardiac dysfunction with breast cancer treatment?

Ecancermedicalscience 2014 17;8:446. Epub 2014 Jul 17.

Department of Medicine, Vanderbilt University School of Medicine, Nashville 37232, TN, USA ; Department of Pharmacology, Vanderbilt University School of Medicine, Nashville TN 37232, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3332/ecancer.2014.446DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4118731PMC
August 2014

An Approach to Breast Cancer Diagnosis via PET Imaging of Microcalcifications Using (18)F-NaF.

J Nucl Med 2014 Jul 15;55(7):1138-43. Epub 2014 May 15.

Vanderbilt University Institute of Imaging Science, Vanderbilt University Medical Center, Nashville, Tennessee Department of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, Tennessee

View Article

Download full-text PDF

Source
http://jnm.snmjournals.org/content/55/7/1138.full.pdf
Web Search
http://jnm.snmjournals.org/cgi/doi/10.2967/jnumed.114.139170
Publisher Site
http://dx.doi.org/10.2967/jnumed.114.139170DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320039PMC
July 2014

Longitudinal, intermodality registration of quantitative breast PET and MRI data acquired before and during neoadjuvant chemotherapy: preliminary results.

Med Phys 2014 May;41(5):052302

Institute of Imaging Science, Vanderbilt University Medical Center, Nashville, Tennessee 37232-2310; Department of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, Tennessee 37232-2675; Department of Physics and Astronomy, Vanderbilt University, Nashville, Tennessee 37240-1807; Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee 37232-6838; Department of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee 37235-1631; and Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee 37232-6838.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1118/1.4870966
Publisher Site
http://dx.doi.org/10.1118/1.4870966DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4000383PMC
May 2014

Stand up to cancer phase Ib study of pan-phosphoinositide-3-kinase inhibitor buparlisib with letrozole in estrogen receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer.

J Clin Oncol 2014 Apr 24;32(12):1202-9. Epub 2014 Mar 24.

Ingrid A. Mayer, Vandana G. Abramson, Justin M. Balko, María Gabriela Kuba, Melinda E. Sanders, and Carlos L. Arteaga, Vanderbilt University, Nashville, TN; Steven J. Isakoff, Massachusetts General Hospital, Boston, MA; Andres Forero, University of Alabama, Birmingham, AL; Jeffrey T. Yap, Huntsman Cancer Institute, Salt Lake City, UT; Annick D. Van den Abbeele and Eric Winer, Dana-Farber Cancer Institute, Boston, MA; Yisheng Li, MD Anderson Cancer Center, Houston, TX; and Lewis C. Cantley, Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2014/03/18/JCO.2013.54
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2013.54.0518
Publisher Site
http://dx.doi.org/10.1200/JCO.2013.54.0518DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986383PMC
April 2014

New strategies for triple-negative breast cancer--deciphering the heterogeneity.

Clin Cancer Res 2014 Feb;20(4):782-90

Authors' Affiliations: Departments of Medicine and Cancer Biology; and Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-0583DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3962777PMC
February 2014

Analyzing Spatial Heterogeneity in DCE- and DW-MRI Parametric Maps to Optimize Prediction of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer.

Transl Oncol 2014 Feb 1;7(1):14-22. Epub 2014 Feb 1.

Institute of Imaging Science, Vanderbilt University, Nashville, TN ; Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN ; Department of Radiology and Radiological Sciences, Vanderbilt University, Nashville, TN ; Department of Biomedical Engineering, Vanderbilt University, Nashville, TN ; Department of Physics, Vanderbilt University, Nashville, TN ; Department of Cancer Biology, Vanderbilt University, Nashville, TN.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998687PMC
http://dx.doi.org/10.1593/tlo.13748DOI Listing
February 2014

Early assessment of breast cancer response to neoadjuvant chemotherapy by semi-quantitative analysis of high-temporal resolution DCE-MRI: preliminary results.

Magn Reson Imaging 2013 Nov 15;31(9):1457-64. Epub 2013 Aug 15.

Department of Radiology and Radiological Sciences, Vanderbilt University, Nashville, TN; Institute of Imaging Science, Vanderbilt University, Nashville, TN; Vanderbilt-Ingram Center, Vanderbilt University, Nashville, TN. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mri.2013.07.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3807825PMC
November 2013

Thrombotic microangiopathy during docetaxel, trastuzumab, and carboplatin chemotherapy for early-stage HER2+ breast cancer: a case report.

Med Oncol 2013 7;30(2):568. Epub 2013 Apr 7.

Department of Internal Medicine, Vanderbilt University Medical Center, D-3100 Medical Center North, Nashville, TN 37232-2358, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12032-013-0568-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3774143PMC
October 2013

Machine learning for predicting the response of breast cancer to neoadjuvant chemotherapy.

J Am Med Inform Assoc 2013 Jul-Aug;20(4):688-95. Epub 2013 Apr 24.

Division of Translational Informatics, Department of Medicine, University of New Mexico, Albuquerque, New Mexico 87131-0001, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/amiajnl-2012-001332DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3721158PMC
September 2013

A mechanically coupled reaction-diffusion model for predicting the response of breast tumors to neoadjuvant chemotherapy.

Phys Med Biol 2013 Sep 6;58(17):5851-66. Epub 2013 Aug 6.

Vanderbilt University Institute of Imaging Science, Vanderbilt University, Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1088/0031-9155/58/17/5851DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791925PMC
September 2013

Parameterizing the Logistic Model of Tumor Growth by DW-MRI and DCE-MRI Data to Predict Treatment Response and Changes in Breast Cancer Cellularity during Neoadjuvant Chemotherapy.

Transl Oncol 2013 Jun 1;6(3):256-64. Epub 2013 Jun 1.

Institute of Imaging Science, Vanderbilt University Medical Center, Nashville, TN ; Department of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, TN.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660793PMC
http://dx.doi.org/10.1593/tlo.13130DOI Listing
June 2013

Complications of targeted drug therapies for solid malignancies: manifestations and mechanisms.

AJR Am J Roentgenol 2013 Mar;200(3):475-83

Department of Radiology and Radiological Science, Vanderbilt University School of Medicine, 1161 21st Ave S, CCC-1121 MCN, Nashville, TN 37232-2675, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2214/AJR.12.9049DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3652983PMC
March 2013

An algorithm for longitudinal registration of PET/CT images acquired during neoadjuvant chemotherapy in breast cancer: preliminary results.

EJNMMI Res 2012 Nov 16;2(1):62. Epub 2012 Nov 16.

Vanderbilt University Institute of Imaging Science, Vanderbilt University, 1161 21st Avenue South, AA-1105 Medical Center North, Nashville, TN 37232-2310, USA.

View Article

Download full-text PDF

Source
http://ejnmmires.springeropen.com/articles/10.1186/2191-219X
Publisher Site
http://dx.doi.org/10.1186/2191-219X-2-62DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3520720PMC
November 2012

Current and emerging quantitative magnetic resonance imaging methods for assessing and predicting the response of breast cancer to neoadjuvant therapy.

Breast Cancer (Dove Med Press) 2012 Oct;2012(4):139-154

Institute of Imaging Science, Vanderbilt University, Nashville, TN, USA ; Department of Radiology and Radiological Sciences, Vanderbilt University, Nashville, TN, USA ; Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/BCTT.S35882DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496377PMC
October 2012

Improving survival and limiting toxicity: latest advances in treating human epidermal growth factor receptor 2 overexpressing breast cancer.

Ther Adv Med Oncol 2012 May;4(3):139-47

Department of Medicine and Breast Cancer Research Program, Vanderbilt-Ingram Comprehensive Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/1758834012440834
Publisher Site
http://dx.doi.org/10.1177/1758834012440834DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349077PMC
May 2012

Clinical utility of serum tumor markers and circulating tumor cell assays in the treatment of breast cancer.

Curr Treat Options Oncol 2011 Dec;12(4):403-11

Division of Hematology/Oncology, Department of Medicine, Vanderbilt University, Vanderbilt-Ingram Cancer Center, Nashville, TN 37212, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11864-011-0164-2
Publisher Site
http://dx.doi.org/10.1007/s11864-011-0164-2DOI Listing
December 2011

New strategies in HER2-overexpressing breast cancer: many combinations of targeted drugs available.

Clin Cancer Res 2011 Mar 19;17(5):952-8. Epub 2011 Jan 19.

Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-6307, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-09-1947DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3761872PMC
March 2011